Efficacy and Safety of Baricitinb in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis

被引：0

作者：

Torrelo, A. ^{[1
]}

Rewerska, B. ^{[2
]}

Paller, Amy ^{[3
]}

Prakash, A. ^{[4
]}

Zhu, D. ^{[4
]}

Pontes, M. ^{[4
]}

Wu, Wen-Shuo ^{[4
]}

Eichenfield, Lawrence F. ^{[5
,6
]}

Boecker, Ulrike ^{[7
]}

机构：

[1] Hosp Infantil Univ San Jose, Bogota, Colombia

[2] Diamond Clin, Krakow, Poland

[3] Univ Northwestern Univ, Feinberg Sch Med, Chicago, IL USA

[4] Eli Lilly & Co, Indianapolis, IN 46285 USA

[5] Univ Calif San Diego, San Diego, CA 92103 USA

[6] Rady Childrens Hosp, San Diego, CA USA

[7] Lilly Deutschland GmbH, Bad Homburg, Germany

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P153

引用

页码：99 / 99

页数：1

共 50 条

[41] Rocatinlimab significantly improves clinical responses in patients with moderate-to-severe atopic dermatitis by week 2 in a randomized double-blind placebo-controlled phase 2b study
Guttman-Yassky, Emma
Esfandiari, Ehsanollah
Mano, Hirotaka
Arai, Takahiro
Kabashima, Kenji
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
[42] Efficacy and safety of lebrikizumab in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis: a phase III randomized, placebo-controlled trial (ADhere)
Simpson, Eric L.
Gooderham, Melinda
Wollenberg, Andreas
Weidinger, Stephan
Armstrong, April
Soung, Jennifer
Ferrucci, Silvia
Lima, Renata Gontijo
Xu, Wen
Witte, Michael M.
Blauvelt, Andrew
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E108 - E108
[43] Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trials
Mendes-Bastos, Pedro
Ladizinski, Barry
Guttman-Yassky, Emma
Jiang, Ping
Liu, John
Prajapati, Vimal H.
Simpson, Eric L.
Vigna, Namita
Teixeira, Henrique D.
Barbarot, Sebastien
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (04) : 784 - 791
[44] Efficacy and safety of adalimumab in Chinese patients with moderate to severe plaque psoriasis: Results from a phase 3, randomized, placebo-controlled, double-blind Study
Zhang, Jianzhong
Gu, Jun
Zheng, Jie
Zheng, Min
Wang, Gang
Gu, Yihua
Okun, Martin
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB232 - AB232
[45] Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: results from two phase III, randomized, double-blinded, placebo-controlled trials
Silverberg, Jonathan I.
Thaci, Diamant
Seneschal, Julien
Gold, Linda Stein
Blauvelt, Andrew
Simpson, Eric
Chu, Chia-Yu
Liu, Zhuqing T.
Lima, Renata Gontijo
Pillai, Sreekumar
Guttman-Yassky, Emma
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E97 - E98
[46] Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
Papp, K. A.
Langley, R. G.
Sigurgeirsson, B.
Abe, M.
Baker, D. R.
Konno, P.
Haemmerle, S.
Thurston, H. J.
Papavassilis, C.
Richards, H. B.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (02) : 412 - 421
[47] Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study
Zheng, Ying
Cai, Guang-Yan
He, Li-Qun
Lin, Hong-Li
Cheng, Xiao-Hong
Wang, Nian-Song
Jian, Gui-Hua
Liu, Xu-Sheng
Liu, Yu-Ning
Ni, Zhao-Hui
Fang, Jing-Ai
Ding, Han-Lu
Guo, Wang
He, Ya-Ni
Wang, Li-Hua
Wang, Ya-Ping
Yang, Hong-Tao
Ye, Zhi-Ming
Yu, Ren-Huan
Zhao, Li-Juan
Zhou, Wen-Hua
Li, Wen-Ge
Mao, Hui-Juan
Zhan, Yong-Li
Hu, Zhao
Yao, Chen
Wei, Ri-Bao
Chen, Xiang-Mei
[J]. CHINESE MEDICAL JOURNAL, 2017, 130 (20) : 2402 - +
[48] Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study
Zheng Ying
Cai Guang-Yan
He Li-Qun
Lin Hong-Li
Cheng Xiao-Hong
Wang Nian-Song
Jian Gui-Hua
Liu Xu-Sheng
Liu Yu-Ning
Ni Zhao-Hui
Fang Jing-Ai
Ding Han-Lu
Guo Wang
He Ya-Ni
Wang Li-Hua
Wang Ya-Ping
Yang Hong-Tao
Ye Zhi-Ming
Yu Ren-Huan
Zhao Li-Juan
Zhou Wen-Hua
Li Wen-Ge
Mao Hui-Juan
Zhan Yong-Li
Hu Zhao
Yao Chen
Wei Ri-Bao
Chen Xiang-Mei
[J]. 中华医学杂志(英文版), 2017, (20) : 2402 - 2409
[49] A new treatment for atopic dermatitis: a randomized double-blind placebo-controlled study
Freeman, S
Day, R
Williams, K
Liauw, W
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB3 - AB3
[50] A multicenter, double-blind, randomized, placebo-controlled, phase IIb dose-finding study to evaluate efficacy and safety of spesolimab in patients with moderate-to-severe palmoplantar pustulosis
Burden, A. David
Bissonnette, Robert
Navarini, Alexander A.
Murakami, Masamoto
Morita, Akimichi
Mozzicato, Susan
Ye, Binqi
Baehner, Frank
Terui, Tadashi
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB131 - AB131

← 1 2 3 4 5 →